{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-249636","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2021-08-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.711710+00:00","generated_at":"2026-06-29T09:19:25.776671+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"SEC ends probe of ORIC CFO Piscitelli with no enforcement action","bullets":["CFO Dominic Piscitelli received SEC subpoena in March 2020 re: trading in unrelated companies.","On August 17, 2021, SEC informed Piscitelli investigation concluded without recommending action.","Investigation pertained solely to personal trading of other companies, not ORIC.","Resolution removes potential overhang for CFO and company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-249636","json":"https://secwatch.observer/filing/0001193125-21-249636.json","markdown":"https://secwatch.observer/filing/0001193125-21-249636.md","text":"https://secwatch.observer/filing/0001193125-21-249636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312521249636/0001193125-21-249636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312521249636/d199524d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T09:19:25.776671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}